A newly selected board of directors for the Center for the Advancement of Science in Space (Casis), will hold its first formal meeting Dec. 13 in Washington, following induction on Nov. 16.

Executive search firm Korn Ferry located seven board members to run the non-profit organization, which was established to manage the U.S. national laboratory portion of the International Space Station (ISS). Casis is responsible for allocating laboratory space to paying customers, and for raising funds and making grants for some research.

An early task for the board will be to find a permanent replacement for James Royston, a former president of Astrotech who was interim executive director of the Florida-based organization. Royston took that role after the original Casis director, Jeanne Becker, resigned in a dispute over the actions of Congress, NASA headquarters and a private consulting firm in setting up the organization. NASA selected Casis to run the national lab on the ISS based on a proposal submitted by Space Florida, that state’s aerospace industrial development agency.

The three interim board members who have been overseeing Casis operations resigned with the establishment of the formal board, Casis says. The new board comprises three scientific members selected for their knowledge of relevant disciplines and familiarity with basic research, and four more tapped for their management and fiduciary experience, according to an announcement of their selection.

Scientists picked to serve on the board are:. Bess Dawson-Hughes, director of the Bone Metabolism Laboratory at Tufts University; Andrei Reuckenstein, vice president of research and associate provost at Boston University; and Gordana Vunjak-Novakovic, professor and vice chair of the Biomedical Engineering Department at Columbia University.

Selected as managing members are: France Cordova, former president of Purdue University who has also served as NASA’s chief scientist; Lewis Duncan, president of Rollins College; Leroy Hood, president of the Institute for Systems Biology; and Dr. Howard Zucker, professor of clinical anesthesiology at the Albert Einstein College of Medicine at Yeshiva University.

The board members’ induction marks the end of a process started by the interim panel this past spring.